Cargando…
Lipid nanoparticle siRNA cocktails for the treatment of mantle cell lymphoma
Mantle cell lymphoma is an aggressive and incurable subtype of non‐Hodgkin B cell lymphoma. Patients typically present with advanced disease, and most patients succumb within a decade of diagnosis. There is a clear and urgent need for novel therapeutic approaches that will affect mantle cell lymphom...
Autores principales: | Knapp, Christopher M., He, Jia, Lister, John, Whitehead, Kathryn A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063866/ https://www.ncbi.nlm.nih.gov/pubmed/30065968 http://dx.doi.org/10.1002/btm2.10088 |
Ejemplares similares
-
Oral delivery of siRNA lipid nanoparticles: Fate in the GI tract
por: Ball, Rebecca L., et al.
Publicado: (2018) -
Lipidoid Nanoparticles for siRNA Delivery to the Intestinal Epithelium: In Vitro Investigations in a Caco-2 Model
por: Ball, Rebecca L., et al.
Publicado: (2015) -
Degradable Lipid Nanoparticles with Predictable In Vivo
siRNA Delivery Activity
por: Whitehead, Kathryn A., et al.
Publicado: (2014) -
Advances in Lipid Nanoparticles for siRNA Delivery
por: Tam, Yuen Yi C., et al.
Publicado: (2013) -
Effect of the amount of cationic lipid used to complex siRNA on the cytotoxicity and proinflammatory activity of siRNA-solid lipid nanoparticles
por: Hanafy, Mahmoud S., et al.
Publicado: (2023)